HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
28 hedge funds and large institutions have $4.24M invested in Hepion Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
-3
Holders Change %
-9.68%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
8
Closed
6
Calls
$145K
Puts
$11K
Net Calls
+$134K
Net Calls Change
-$488K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$61.6K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$25.9K |
| 3 |
VF
Virtu Financial
New York
|
+$13K |
| 4 |
Jane Street
New York
|
+$9.78K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.83K |
Top Sellers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$98.6K |
| 2 |
Two Sigma Advisers
New York
|
-$20.3K |
| 3 |
State Street
Boston,
Massachusetts
|
-$20K |
| 4 |
Goldman Sachs
New York
|
-$19K |
| 5 |
JWM
JGP Wealth Management
Bend,
Oregon
|
-$17K |
